NASDAQ: NEOGNeogen Corp Stock Ownership - Who owns Neogen?
Insider buying vs selling
Have Neogen Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| David H. Naemura | CFO | 2024-11-29 | 5,371 | $14.14 | $75.95kSell |
| David H. Naemura | CFO | 2024-11-29 | 12,911 | $14.14 | $182.56kBuy |
| Thierry Bernard | Director | 2024-11-01 | 5,620 | $14.44 | $81.15kBuy |
| Jeffrey D. Capello | Director | 2024-10-28 | 1,776 | $13.81 | $24.53kBuy |
| James P. Tobin | Director | 2024-10-28 | 1,776 | $13.81 | $24.53kBuy |
| Rafael A. Rodriguez | Director | 2024-10-28 | 1,776 | $13.81 | $24.53kBuy |
| David H. Naemura | Chief Financial Officer | 2024-10-28 | 15,504 | $13.81 | $214.11kBuy |
| David H. Naemura | Chief Financial Officer | 2024-10-28 | 6,450 | $13.81 | $89.07kSell |
| Douglas Edward Jones | Chief Operating Officer | 2024-10-28 | 15,504 | $13.81 | $214.11kBuy |
| William T. Boehm | Director | 2024-10-28 | 1,776 | $13.81 | $24.53kBuy |
NEOG insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when NEOG insiders and whales buy or sell their stock.
NEOG Shareholders
What type of owners hold Neogen Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc 1 | 11.78% | 25,518,040 | $327.14M | Institution |
| Vanguard Group Inc | 9.10% | 19,708,760 | $252.67M | Institution |
| William Blair Investment Management LLC | 6.12% | 13,271,934 | $170.15M | Institution |
| Select Equity Group LP | 6.11% | 13,241,197 | $169.75M | Institution |
| Baillie Gifford Co | 5.18% | 11,227,219 | $143.93M | Institution |
| Conestoga Capital Advisors LLC | 4.02% | 8,706,224 | $111.61M | Institution |
| State Street Corp | 3.66% | 7,932,192 | $101.69M | Institution |
| Mackenzie Financial Corp | 3.42% | 7,402,426 | $94.90M | Institution |
| Bamco Inc | 3.37% | 7,303,115 | $93.63M | Institution |
| Champlain Investment Partners LLC | 3.28% | 7,110,530 | $91.16M | Institution |
NEOG vs Diagnostic & Research Stocks
Neogen Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.